Dublin, Feb. 05, 2025 (GLOBE NEWSWIRE) — The “Mycotoxin Testing Market – Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Mycotoxin Testing Market was valued at USD 1.34 Billion in 2024, and is expected to reach USD 2.08 Billion by 2030, rising at a CAGR of 7.56%
Mycotoxins are highly toxic secondary metabolites produced by fungi. These contaminants pose significant health risks to humans and animals, including fatality or severe medical complications, making their presence in food products a critical issue. Mycotoxins thrive in humid environments with organic matter and suitable temperatures, with fungal growth accelerating under favorable conditions. This leads to colony formation and an elevated risk of contamination.
Despite extensive research, the underlying reasons for mycotoxin production remain elusive. However, their prevalence in food products is well-documented. Even trace amounts can compromise the chemical integrity of the host material, facilitating further fungal proliferation. The variability in mycotoxin toxicity depends on factors such as the host’s metabolic activity, immunity, and environmental conditions.
For businesses in the food and related industries, mycotoxin testing is not just a regulatory requirement but a critical operational mandate. Compliance with stringent international and regional food safety standards is non-negotiable to ensure product integrity and consumer trust. Organizations must implement robust testing protocols to mitigate contamination risks, avoid regulatory penalties, and maintain market reputation.
Expansion Opportunities in Emerging Markets
Increasing food trade across borders in emerging markets presents opportunities for market growth. The rising prevalence of food-borne illnesses and inadequate sanitation and processing conditions in certain countries, like Indonesia, underscores the necessity for mycotoxin testing of food. China, as a prominent food-importing and -exporting nation, plays a pivotal role in the mycotoxin testing market. The implementation of regulations in emerging economies engaged in food trade, empowering authorities to prohibit the import and supply of contaminated food, enforce food recalls, and mandate nutrition labeling, is anticipated to drive the demand for testing services in these regions.
The escalating occurrences of mycotoxicosis outbreaks in the emerging economies of Asia and Africa present significant growth prospects for mycotoxin testing in these areas. Developing countries are consistently exposed to high levels of aflatoxins, fumonisins, and trichothecenes, which are known to cause carcinogenicity, immunotoxicity, and growth retardation in animals.
Multiple studies conducted in Nigeria have reported toxin levels far exceeding the limits set by international regulatory agencies in food and agricultural products. There have been widespread reports of fatal outbreaks of toxicities, particularly due to aflatoxins, in Nigeria. Addressing the food safety and international trade concerns associated with mycotoxin contamination in Nigerian consumer goods and agricultural products is of utmost urgency. Developing countries like Nigeria face significant challenges due to a lack of organized scientific information and data on the magnitude of the problem.
Growing Consumer Awareness
The global mycotoxin testing market is expected to experience significant growth due to the increasing number of consumers who are cognizant of the impact of food ingredients on their health. This awareness is facilitated by the availability of information on the internet and the proactive efforts of regional health departments in educating the public about the risks associated with consuming harmful compounds. As consumer awareness continues to grow, corporations are compelled to provide accurate information to attract new customers and preserve brand value.
Segmental Insights
Type Insights
Based on Type, the market is divided into Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, and Others. Aflatoxins dominated the Global Mycotoxin Testing Market due to several factors that highlight their significance in food safety and regulatory compliance. Aflatoxins are highly toxic secondary metabolites produced by certain fungi, primarily Aspergillus species, which commonly contaminate food and feed crops such as maize, peanuts, and tree nuts.
These toxins pose severe health risks to humans and animals, including carcinogenic, mutagenic, and immunosuppressive effects, making their detection and regulation paramount in ensuring public health and food safety. One of the key reasons for the dominance of aflatoxins in the mycotoxin testing market is their widespread occurrence and persistence in agricultural commodities across the globe. Aflatoxin contamination is prevalent in regions with warm and humid climates, where conditions favor fungal growth and toxin production. As a result, aflatoxin contamination poses a significant challenge to food producers, processors, and regulatory authorities worldwide, necessitating robust testing protocols and monitoring programs to mitigate risks to human and animal health.
Aflatoxins have garnered considerable attention from regulatory agencies and international organizations due to their potent toxicity and adverse health effects. Regulatory bodies such as the Food and Drug Administration (FDA), European Food Safety Authority (EFSA), and World Health Organization (WHO) have established strict regulatory limits and guidelines for aflatoxin levels in food and feed products, mandating routine testing and compliance measures by food manufacturers, importers, and exporters.
Technology Insights
Based on technological advancements, the global market is categorized into HPLC-based, LC-MS/MS-based, Immunoassay-based, Others segments. The high-performance liquid chromatography (HPLC) segment is anticipated to emerge as the fastest-growing segment within the global market, driven by its exceptional capability to precisely quantify plasma levels of drugs and their metabolites. In the realm of medical diagnostics and pharmaceutical research, the accuracy of diagnosis and treatment efficacy hinges upon the precise determination of concentrations of biogenic substances within biological samples. Herein lies the strength of HPLC, which enables healthcare professionals and researchers to obtain highly accurate and reliable measurements of analytes in complex sample matrices.
The adoption of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has witnessed remarkable growth, emerging as one of the most potent analytical techniques in the field. LC-MS/MS seamlessly integrates the capabilities of liquid chromatography with the sensitivity and selectivity of triple quadrupole mass spectrometry, thereby offering unparalleled advantages in terms of detection, quantification, and identification of analytes. This hybrid approach empowers analysts to achieve exceptional levels of sensitivity and specificity, even in the presence of interfering compounds or complex sample matrices.
One of the key drivers behind the proliferation of LC-MS/MS in clinical and research settings is its ability to address the evolving demands for comprehensive and reliable analytical solutions. LC-MS/MS enables simultaneous quantification of multiple analytes within a single sample, facilitating efficient and cost-effective analysis while maximizing throughput and productivity. Although the initial investment and operational costs associated with LC-MS/MS instrumentation may be relatively high, the benefits it offers in terms of sensitivity, specificity, and efficiency far outweigh the associated expenses.
Regional Insights
Based on region, the mycotoxin testing market is segmented into North America, Europe, Asia Pacific, South America, and MEA. Europe (EU) is expected to lead the global mycotoxin testing market due to the implementation of stringent regulations pertaining to animal feed. The European Feed and Food Ingredient Safety Certification plays a crucial role in regulating the animal feed market within the region. Growth in Asia-Pacific is anticipated to be driven by the increasing consumer awareness regarding food ingredients and the growing emphasis of regional governments on conducting comprehensive tests before introducing products to the market.
The presence of rigorous food safety regulations established by the US Food and Drugs Administration department is likely to propel revenue growth in North America to unprecedented levels. One of the key drivers for the current growth is the stringent regulations in countries such as Germany, the US, France, and the UK. The UK exhibits the slowest growth rate in the European region. However, the Asia Pacific region is expected to experience a significant boost in the mycotoxin testing market in the coming years due to rapid urbanization. The market is currently constrained by the lack of food control systems, bacterial detection devices, and the casual attitude of developing economies towards high R&D costs. Nevertheless, these factors present opportunities for further development and growth in the mycotoxin market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $1.34 Billion |
| Forecasted Market Value (USD) by 2030 | $2.08 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Report Scope:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Mycotoxin Testing Market.
- SGS Societe Generale de Surveillance SA.
- Bureau Veritas
- Eurofins Scientific
- Intertek Group plc
- Merieux NutriSciences Corporation
- ALS Limited
- Neogen Corporation
- AsureQuality Limited.
- Charm Sciences, Inc.
- Premier Analytical Services
Mycotoxin Testing Market, By Type:
- Aflatoxin
- Deoxynivalenol
- Ochratoxins
- Fumonisins
- Others
Mycotoxin Testing Market, By Technology:
- HPLC-based
- LC-MS/MS-based
- Immunoassay-based
- Others
Mycotoxin Testing Market, By Sample:
Mycotoxin Testing Market, By End User:
- Research Lab
- Research Institutes
- Food Testing Industries
- Feed Testing Industries
- Others
Mycotoxin Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
For more information about this report visit https://www.researchandmarkets.com/r/cis44a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
